- Home
- AVO vs XERS Comparison
AVO vs XERS Comparison
Compare AVO & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVO
- XERS
- Stock Information
- Founded
- AVO 1983
- XERS 2005
- Country
- AVO United States
- XERS United States
- Employees
- AVO N/A
- XERS N/A
- Industry
- AVO Farming/Seeds/Milling
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- AVO Consumer Staples
- XERS Health Care
- Exchange
- AVO Nasdaq
- XERS Nasdaq
- Market Cap
- AVO 893.3M
- XERS 1.3B
- IPO Year
- AVO 2020
- XERS 2018
- Fundamental
- Price
- AVO $12.51
- XERS $7.83
- Analyst Decision
- AVO Strong Buy
- XERS Strong Buy
- Analyst Count
- AVO 2
- XERS 7
- Target Price
- AVO $15.50
- XERS $8.00
- AVG Volume (30 Days)
- AVO 238.3K
- XERS 3.5M
- Earning Date
- AVO 09-08-2025
- XERS 08-07-2025
- Dividend Yield
- AVO N/A
- XERS N/A
- EPS Growth
- AVO 108.17
- XERS N/A
- EPS
- AVO 0.52
- XERS N/A
- Revenue
- AVO $1,392,900,000.00
- XERS $246,025,000.00
- Revenue This Year
- AVO $8.85
- XERS $43.89
- Revenue Next Year
- AVO N/A
- XERS $20.40
- P/E Ratio
- AVO $24.17
- XERS N/A
- Revenue Growth
- AVO 29.50
- XERS 35.62
- 52 Week Low
- AVO $9.56
- XERS $2.48
- 52 Week High
- AVO $15.25
- XERS $8.02
- Technical
- Relative Strength Index (RSI)
- AVO 53.38
- XERS 75.74
- Support Level
- AVO $12.31
- XERS $7.27
- Resistance Level
- AVO $12.74
- XERS $8.02
- Average True Range (ATR)
- AVO 0.25
- XERS 0.29
- MACD
- AVO -0.01
- XERS -0.00
- Stochastic Oscillator
- AVO 43.06
- XERS 79.35
About AVO Mission Produce Inc.
Mission Produce Inc is engaged in the business of producing and distributing avocados, serving retail, wholesale, and food service customers. Also, the company provides additional services like ripening, bagging, custom packing, and logistical management. The company's operating segments include Marketing and Distribution, International Farming and Blueberries. It generates maximum revenue from the Marketing and Distribution segment. The Marketing and Distribution segment sources fruit mainly from growers and then distributes fruit through a distribution network. Geographically distributed across North America, China, Europe, and the U.K.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).